PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: CHUSEI (USA), Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Phyto-Source, L.P. Updates Phytosterol Capacity Expansion - Phyto-Source, L.P., one of the world's leading suppliers of high purity, non-GMO wood (plant) derived sterols, has made significant progress in increasing capacity at their manufacturing facility in Houston, Texas - ChuseiUSA.com
Phyto-Source, L.P. Updates Phytosterol Capacity Expansion

 

NewswireToday - /newswire/ - Pasadena, TX, United States, 2007/06/07 - Phyto-Source, L.P., one of the world's leading suppliers of high purity, non-GMO wood (plant) derived sterols, has made significant progress in increasing capacity at their manufacturing facility in Houston, Texas - ChuseiUSA.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In January, 2007, Phyto-Source’s plant capacity was successfully increased by over forty percent to meet the increased demand for the company’s cholesterol-lowering food ingredient, Phyto-S-Sterol™. Further process debottlenecking initiatives, technology improvements, and capital additions have resulted in an additional thirty percent capacity increase. The plant’s total output is now 3000 MT per year.

Bill Sonnier, President and CEO of Chusei (USA) and Manager of Phyto-Source, notes that “this recent expansion of our ability to produce high quality phytosterols is our second step in our goal to significantly increase our production volume and capabilities. There will be further expansion of capacity and product varieties at our Houston facility in the near term. We are also moving forward with plans to build a major manufacturing plant in Europe so that we can better serve that market’s growing need for phytosterols.”

Sonnier went on to say “Phyto-Source is well positioned to meet the requirements for new applications and customers in the sterol marketplace. The global market for phytosterols is expanding and Phyto-Source is prepared for this development through the application of is proprietary, state-of-the-art technology. By expanding our capacity in Houston and building new capacity in Europe, Phyto-Source will continue to build its leadership position”

Phyto-Source, L.P. (phytosourcelp.com) is a leading producer of high-quality non-Genetically Modified (non-GM) wood (plant) sterols and serves a growing list of customers around the world.

Chusei (U.S.A.) Inc. (chuseiusa.com) serves the custom chemical manufacturing industry through its manufacturing facility located in the Houston, Texas area. Chusei also serves as the operating partner for Phyto-Source, L.P.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: CHUSEI (USA), Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Phyto-Source, L.P. Updates Phytosterol Capacity Expansion

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Thomas Stegmann - PhytoSourceLP.com 
281-291-7990 x18 tom.stegmann[.]phytosourcelp.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any CHUSEI (USA), Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From CHUSEI (USA), Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)